This is a really important trial in patients with T2DM, and will be another medication in the cupboard for slowing the progression of CKD
FDA Approves ruxolitinib (Opzelura) for vitiligo therapy: A breakthrough in the field of dermatology
In contrast, severe hypoglycemia may present with lethargy, delirium, disorientation, seizures, and even coma [46, 47]
This hormone stimulates melanin production without the need for direct UV exposure
The practical stakes for patients are enormous
Arrhythmias, in non-structural heart disease, regarded as heterogeneous pathology, worldwidely, affect 0.8-1,4% of the general population, being three times more common in females than in males